Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SCT”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Early research (Phase 1)Ended earlyNCT00621556
What this trial is testing

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

Who this might be right for
Intraductal Papillary Mucinous Neoplasms
Massachusetts General Hospital 2
Early research (Phase 1)Study completedNCT02655458
What this trial is testing

Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hearn Jay Cho 15
Testing effectiveness (Phase 2)Looking for participantsNCT06453460
What this trial is testing

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Who this might be right for
CMVAllogeneic Stem Cell Transplantation
University of California, Irvine 50
Early research (Phase 1)Study completedNCT03862833
What this trial is testing

Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nantes University Hospital 30
Not applicableLooking for participantsNCT07537738
What this trial is testing

Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)MLL Rearrangement
Peking University People's Hospital 210
Large-scale testing (Phase 3)UnknownNCT01423500
What this trial is testing

ALL-SCT BFM International- HSCT in Children and Adolescents With ALL

Who this might be right for
Lymphoblastic Leukemia, Acute, Childhood;
St. Anna Kinderkrebsforschung 405
Not applicableUnknownNCT02872662
What this trial is testing

Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT

Who this might be right for
MDSSCTMRD
Nordic MDS Group 200
Not applicableStudy completedNCT00386373
What this trial is testing

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT02812940
What this trial is testing

Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCT

Who this might be right for
Graft-versus-Host Disease
University of Cologne 19
Large-scale testing (Phase 3)Study completedNCT00660335
What this trial is testing

Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas

Who this might be right for
Pancreatitis
Repligen Corporation 258
Testing effectiveness (Phase 2)Study completedNCT00235274
What this trial is testing

Effects of RG1068 (Secretin) on Information Processing in Schizophrenia

Who this might be right for
Schizophrenia
Indiana University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT00505895
What this trial is testing

FM 140 vs FM100 Study in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 52
Not applicableLooking for participantsNCT05235867
What this trial is testing

Secretin in Refeeding

Who this might be right for
Anorexia in Adolescence
University of California, Los Angeles 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT01499888
What this trial is testing

Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
University of Illinois at Chicago 45
Not applicableActive Not RecruitingNCT05135052
What this trial is testing

Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.

Who this might be right for
Non-melanoma Skin Cancer
OncoBeta Therapeutics 210
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Testing effectiveness (Phase 2)Ended earlyNCT00531310
What this trial is testing

Reduced Intensity AlloSCT in(CML) With Persistent Disease

Who this might be right for
Chronic Myeloid Leukemia
Columbia University 5
Not applicableUnknownNCT01891877
What this trial is testing

Sickle Cell Trait in Football Players

Who this might be right for
Sickle Cell Trait
University of South Florida 20
Testing effectiveness (Phase 2)Study completedNCT01265875
What this trial is testing

Secretin Infusion for Pain Due to Chronic Pancreatitis

Who this might be right for
Chronic Pancreatitis
ChiRhoClin, Inc. 12
Early research (Phase 1)Study completedNCT00875693
What this trial is testing

A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Weill Medical College of Cornell University 47
Load More Results